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A decline in podocyte number correlates with progression to
glomerulosclerosis. A mechanism underlying reduced
podocyte number is the podocyte’s relative inability to
proliferate in response to injury. Injury by the podocyte toxin
puromycin aminonucleoside (PA) is mediated via reactive
oxygen species (ROS). The precise role of ROS in the
pathogenesis of PA-induced glomerulosclerosis remains to
be determined. We sought to examine whether PA-induced
ROS caused podocyte DNA damage, possibly accounting for
the podocyte’s inability to proliferate in response to PA. In
vitro, podocytes were exposed to PA, with or without the
radical scavenger 1,3-dimethyl-2-thiourea (DMTU). In vivo,
male Sprague–Dawley rats were divided into experimental
groups (n¼ 6/group/time point): PA, PA with DMTU, and
control, killed at days 1.5, 3, or 7. DNA damage was measured
by DNA precipitation, apurinic/apyrimidinic site, Comet, and
8-hydroxydeoxyguanosine assays. Cell cycle checkpoint
protein upregulation (by immunostaining and Western
blotting), histopathology, and biochemical parameters were
examined. DNA damage was increased in cultured podocytes
that received PA, but not PA with DMTU. PA exposure
activated specific cell cycle checkpoint proteins, with
attenuation by DMTU. DNA repair enzymes were activated,
providing evidence for attempted DNA repair. The PA-treated
animals developed worse proteinuria and histopathologic
disease and exhibited more DNA damage than the DMTU
pretreated group. No significant apoptosis was detected by
terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling staining. A mechanism underlying the lack of
podocyte proliferation following PA-induced injury in vitro
and in vivo may be ROS-mediated DNA damage, with
upregulation of specific cell cycle checkpoints leading to cell
cycle arrest.
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The glomerular visceral epithelial cell, or podocyte, is a
highly specialized and terminally differentiated cell that
forms a critical part of the glomerular filtration barrier and
functions to prevent urinary protein leakage, maintain
glomerular capillary loop integrity, oppose intracapillary
hydrostatic pressure, and synthesize the glomerular basement
membrane.1 Common to many human kidney diseases and
experimental animal models is a strong association between
podocyte injury and glomerulosclerosis. Studies have de-
monstrated that a decline in podocyte number strongly
correlates with, and likely underlies, progression to glomer-
ulosclerosis.2–6 Two important mechanisms for podocyte
depletion following injury are apoptosis and detachment.
Podocyte loss leads to areas of denuded basement membrane,
culminating in proteinuria, the development of focal
glomerulosclerosis, and progressive deterioration in kidney
function.
Owing to their highly differentiated state, mature podo-
cytes readily do not proliferate in vivo. Therefore, the
apparent lack of proliferation in response to injury con-
tributes to reduced podocyte number.2 At the cell cycle level,
reduced proliferation is a consequence of either an abnorm-
ality in DNA synthesis, secondary to G1/S checkpoint arrest,
or reduced mitosis, secondary to G2/M checkpoint arrest.
DNA damage triggers activation of cell cycle checkpoints,
molecular pathways that monitor passage through the cell
cycle and generate pauses in cell cycle progression when DNA
damage is present. Thus, DNA damage leads to cell cycle
arrest, permitting the cell sufficient time for DNA repair or
other cell fate decisions, including apoptosis or entry into a
permanent senescence-like state, thereby limiting prolifera-
tion.7 Cell cycle arrest following DNA damage is mediated, in
part, by tumor suppressor p53 and cyclin-dependent kinase
inhibitor p21WAF1/CIP1. It is unknown whether the presence of
DNA damage, with subsequent cell cycle arrest, accounts for
the podocyte’s limited proliferation in non-immune-medi-
ated podocyte injury, namely puromycin aminonucleoside
nephropathy (PAN).
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Puromycin aminonucleoside (PA), a podocyte toxin used
to induce experimental minimal change disease progressing
to focal segmental glomerulosclerosis in rats, leads to
podocyte foot process effacement, and massive proteinuria
within 7–10 days. In vivo studies have supported that, acutely,
PA-induced glomerular injury is mediated via overproduc-
tion of reactive oxygen species (ROS),8–14 which then may
interact with biomolecules, leading to modification and
potentially deleterious cellular consequences.15 This study
was designed to examine whether DNA damage occurs in
PAN, if DNA damage accounts for the inability of podocytes
to proliferate in response to the toxin PA, and which cell cycle
regulatory proteins may underlie this response.
RESULTS
DNA damage in cultured podocytes exposed to PA,
oxidant-dependent
To determine whether PA induced DNA damage in vitro,
growth-restricted podocytes were exposed to PA, and DNA
damage was measured by three methods. DNA precipitation
assay results are shown in Figure 1. As there is a basal level of
oxidative DNA damage owing to non-pathogenic metabolic
processes in healthy aerobic organisms,15,16 the amount of
single-stranded DNA (ssDNA) present in control cells at the
earliest time point was considered the reference. This basal
level of ssDNA was subtracted from subsequent values for all
conditions and time points. At 6 h, there was a significant
difference in the percent ssDNA between podocytes exposed to
PA versus control conditions (control¼ 22.43%, PA¼ 37.08%;
Po0.05). There was no significant difference between these
two groups at 2 and 24 h. Podocytes exposed to PAþ 1,3-
dimethyl-2-thiourea (DMTU) exhibited a lower percent
ssDNA at 6 and 24 h than cells exposed to PA alone, with
values falling below the basal level observed in control cells.
To confirm that PA mediates DNA damage, the results of
the AP (apurinic/apyrimidinic or abasic) site assay are shown
in Figure 2. With PA exposure, there were an increased
number of abasic sites in DNA at 6 and 18 h (values per
100 000 base pairs: 6 h: control¼ 0.102, PA¼ 14.649,
Po0.05; 18 h: control¼ 1.396, PA¼ 2.689, Po0.05). In
podocytes exposed to PAþDMTU, DNA damage was
lessened, with no significant increase in abasic sites when
compared to controls (6 h: 0.078, 18 h: 1.441). Cells exposed
to H2O2, the positive control for oxidant-mediated DNA
damage, exhibited levels of abasic sites intermediate between
control and PA groups (data not shown).
As further corroboration that PA mediates DNA damage
in podocytes, the results of the Comet assay are shown in
Figure 3. Following exposure to experimental conditions,
podocytes underwent harvesting, immobilization in agarose,
gentle lysis, and alkaline electrophoresis. With PA exposure,
there was an increase in cells exhibiting long ‘comet tails’,
when compared to control group (Figure 3a and c), at 2 and
6 h (values per 200 cells: 2 h: control¼ 0.8, PA¼ 7, Po0.05;
6 h: control¼ 1.2, PA¼ 22, Po0.05) (Figure 3d). In podo-
cytes exposed to PAþDMTU, DNA damage was lessened,
with a decrease in long ‘comet tails’ when compared to
PA-exposed cells (2 h: PAþDMTU¼ 1.8, Po0.05; 6 h:
PAþDMTU¼ 7, Po0.05) (Figure 3b).
The results from the DNA precipitation, AP site, and
Comet assays demonstrated that PA caused DNA damage in
cultured podocytes. This DNA damage was attenuated by
pre-exposure to DMTU, providing support that PA mediated
oxidative DNA damage.
Cell cycle checkpoint activation in cultured podocytes
exposed to PA, oxidant-dependent
In contrast to other glomerular cells, podocytes typically do
not proliferate following injury. To test the hypothesis that
following PA-mediated oxidative DNA damage, cell cycle
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Figure 1 | PA-induced DNA damage in cultured podocytes,
attenuated by pre-exposure to DMTU: DNA precipitation assay.
The ssDNA was measured by the DNA precipitation assay, performed
on cultured podocytes following exposure to PA 30 mg/ml at time
points 2, 6, and 24 h, with or without pre-exposure to the antioxidant
DMTU 10 mM. PA induced significant DNA damage at time points 6
and 24 h, an effect reduced by DMTU. As there is a basal quantity of
ssDNA owing to endogenous processes, the level of ssDNA present
in the control cells at the earliest time point was the reference point
for all other measurements and this level of baseline ssDNA was
subtracted from other values. *Po0.05, for PA versus PAþDMTU.
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Figure 2 | PA-induced DNA damage in cultured podocytes,
attenuated by pre-exposure to DMTU: AP site assay. Abasic sites
were measured by the AP site assay in cultured podocytes following
exposure to PA 30 mg/ml at time points 2, 6, 18, and 24 h, with or
without pre-exposure to DMTU 10 mM. Following exposure to PA,
at 6 and 18 h, there was a statistically significant increase in abasic
sites compared with time-matched controls, an effect reduced
by DMTU. *Po0.05, for PA versus PAþDMTU.
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checkpoint proteins are activated thereby limiting prolifera-
tion, Western blotting was performed on extracts from
cultured podocytes (Figure 4). At 6 and 24 h after PA
exposure, protein expression was increased for p21WAF1/CIP1
(ratio to control: 5.24 at 6 h, 2.28 at 24 h) and p53 (ratio to
control: 2.27 at 6 h, 1.91 at 24 h). In podocytes pretreated
with DMTU, the levels of p21WAF1/CIP1 (ratio to control: 0.98
at 6 h, 1.02 at 24 h) and p53 (ratio to control: 1.16 at 6 h, 0.89
at 24 h) were reduced compared to the PA-only group. The
expression levels of checkpoint proteins checkpoint kinase 1
(CHK-1), checkpoint kinase 2 (CHK-2), and growth arrest,
DNA damage-inducible-45a were not significantly different
between PA and PAþDMTU groups at 6 and 24 h (data not
shown).
These results established that specific cell cycle checkpoint
proteins were activated in response to PA-mediated oxidative
DNA damage. Following pre-exposure to DMTU, PA did not
induce the same level of cell cycle checkpoint protein
activation.
DNA repair enzyme activation in cultured podocytes exposed
to PA, oxidant-dependent
To determine if podocytes possessed the capacity to repair
damaged DNA, specific DNA repair enzymes were evaluated.
Figure 5 shows that, in addition to upregulation of cell cycle
checkpoint proteins in response to PA-mediated oxidative
DNA damage, there was also upregulation in DNA repair
enzymes AP-endonuclease and DNA polymerase-b. By
Western blotting, at 6 and 24 h, there was increased protein
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Figure 3 | PA-induced DNA damage in cultured podocytes, attenuated by pre-exposure to DMTU: Comet (single-cell gel
electrophoresis) assay. Damaged DNA was measured by the Comet assay in cultured podocytes following exposure to PA 30 mg/ml at time
point 2, 6, and 24 h, with or without pre-exposure to DMTU 10 mM (original magnification 20). (a) Representative micrograph of fluorescent
DNA stain of control cells, showing undamaged and supercoiled DNA remaining within the nuclear cell membrane. (b) Representative
micrograph of fluorescent DNA stain of PAþDMTU-exposed cells, showing mild degree of denatured DNA fragments migrating out from
cell. (c) Representative micrograph of fluorescent DNA stain of PA-exposed cells, showing denatured DNA fragments migrating out from
cell in a long ‘comet tail’. (d) Quantification of podocytes with long ‘comet tails’. Following exposure to PA, at 2, 6, and 24 h, there was
a statistically significant increase in the number of cells with long ‘comet tails’ compared with time-matched controls. DMTU significantly
lessened PA-induced DNA damage at time points 2 and 6 h. *Po0.05, for PA versus PAþDMTU.
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Figure 4 | Activation of cell cycle checkpoint proteins in cultured
podocytes, following exposure to PA, attenuated by DMTU.
(a) p21WAF1/CIP1 protein expression. The protein expression of
p21WAF1/CIP1 was increased by a ratio of 5.24 and 2.28 in PA-exposed
cells, compared to time-matched controls, at time points 6 and 24 h,
respectively. With DMTU pre-exposure, the ratio decreased to 0.98
and 1.0, at time points 6 and 24 h, respectively. Values are averages of
three separate experiments and are normalized for differences in
protein loading. (b) p53 protein expression. The protein expression of
p53 was increased by a ratio of 2.27 and 1.91 in PA-exposed cells,
compared to time-matched controls, at time points 6 and 24 h,
respectively. With DMTU pre-exposure, the ratio decreased to 1.16
and 0.89, at time points 6 and 24 h, respectively. Values are averages
of three separate experiments and are normalized for differences in
protein loading. (c) Western blot analysis. Representative Western
blots for p21WAF1/CIP1 and p53 are shown. Actin and glyceraldehyde-
3-phosphate dehydrogenase were used as housekeeping proteins to
ensure equal protein loading. The results show that p21WAF1/CIP1 and
p53 protein levels increased following exposure to PA. This was
reduced by DMTU.
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expression of AP-endonuclease (ratio to control: 3.24 at 6 h,
1.96 at 24 h) and DNA polymerase-b (ratio to control: 7.1 at
6 h, 1.34 at 24 h) following PA exposure. Upon exposure
to PA with DMTU, the levels were decreased at 6 and 24 h
(AP-endonuclease ratio to control: 1.51 at 6 h, 1.13 at 24h;
DNA polymerase-b ratio to control: 1.65 at 6 h, 0.33 at 24 h).
These results demonstrated that DNA repair enzymes
AP-endonuclease and DNA polymerase-b were activated
following PA exposure, providing indirect support that
DNA damage was present and that the ‘appropriate’ response
to injury was activated in podocytes. Decreased repair
enzyme activation was seen in podocytes exposed to
PAþDMTU, further supporting that DNA damage was
oxidant-dependent.
Proteinuria and histopathology in PAN, oxidant-dependent
There was no significant difference in plasma blood urea
nitrogen measurements in rats receiving PA versus PAþDM-
TU (data not shown). However, by day 7, rats receiving
PA alone had significantly greater proteinuria than rats
pretreated with DMTU (PA¼ 28.73 mg/24h; PAþDMTU¼
15.85 mg/24 h; Po0.05) (Figure 6a). To semiquanti-
tatively assess the severity of glomerular injury, a glomerular
sclerosis index was calculated by examining histopathologic
sections stained with periodic acid-Schiff, as described
previously,17–19 using the following scale: 0¼ normal glomer-
ulus, 1¼ sclerotic area p25% of glomerular area,
2¼ 25–50% of glomerular area, 3¼ 50–75% of glomerular
area, and 4¼ global sclerosis. The glomerular sclerosis index
was calculated by multiplying the number of glomeruli with a
sclerosis score of 1 by one, 2 by two, and so on. These values
were summed to obtain the final glomerular sclerosis index.
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Figure 5 | Induction of DNA repair enzymes apurinic/apyrimidinic
endonuclease (APE) and DNA polymerase-b (DNA poly-b)
following treatment with PA, attenuated by DMTU. (a) APE
protein expression. The protein expression of APE was increased by
a ratio of 3.24 and 1.96 in PA-exposed cells, compared with time-
matched controls, at time points 6 and 24 h, respectively. With DMTU
pre-exposure, the ratio decreased to 1.51 and 1.13, at time points 6
and 24 h, respectively. Values are averages of three separate
experiments and are normalized for differences in protein loading.
(b) DNA poly-b protein expression. The protein expression of DNA
poly-b was increased by a ratio of 7.1 and 1.34 in PA-exposed cells,
compared with time-matched controls, at time points 6 and 24 h,
respectively. With DMTU pre-exposure, the ratio was decreased to
1.65 and 0.33, at time points 6 and 24 h, respectively. Values are
averages of three separate experiments and are normalized for
differences in protein loading. (c) Western blot analysis.
Representative Western blots for APE and DNA poly-b are shown.
Tubulin was used as a housekeeping protein to ensure equal protein
loading. The results show that APE and DNA poly-b protein levels
increased following exposure to PA. This was reduced by DMTU.
Arrows indicate band of interest.
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Figure 6 | Protein excretion and histopathologic changes by periodic acid-Schiff (PAS) staining following treatment with PA, with or
without pre-exposure to DMTU. (a) Proteinuria. By day 7, rats receiving PA alone had a statistically significantly greater degree of protein
excretion than rats pretreated with DMTU. *Po0.05. (b) Sclerosis index. Tissue from rats receiving PA alone exhibited greater disease severity as
semiquantitatively assessed by sclerosis index. The number of early glomerular sclerotic lesions was reduced in the PAþDMTU group (Po0.05).
(c) Histopathology (original magnification  40). Representative micrographs of PAS staining of tissues are shown (c¼ control, d¼ PA, and
e¼ PAþDMTU). Tissue from rats receiving PA alone exhibited greater disease severity than rats that received PAþDMTU.
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Consistent with the proteinuria data, there was a significant
difference in glomerular sclerosis index among the groups
(control¼ 2, PA¼ 34, PAþDMTU¼ 7.8) (Figure 6b). The
histopathology from the PA group was typified by marked
acute tubular injury with proteinaceous casts and cytoplas-
mic protein absorption droplets, and evidence of early
segmental glomerular sclerotic lesions (Figure 6d). These
results provided supporting data that PA induced glomerular
and tubular injury, mediated by ROS.
DNA damage in PAN, oxidant-dependent
To determine if oxidant-dependent DNA damage was
induced in vivo, DNA damage was measured by the AP site
assay on isolated glomeruli. At the earliest time point, there
was a significant difference in the number of abasic sites
between the PA and PAþDMTU groups (PA¼ 17.13/
100 000 bp, PAþDMTU¼ 3.06/100 000 bp; Po0.05) (Figure
7a). Beyond this time point, the difference between the
groups diminished and was no longer significant.
To confirm the presence of DNA damage, immunostaining
for 8-hydroxydeoxyguanosine (8-OHdG), an oxidized nu-
cleotide commonly a byproduct of ROS-mediated DNA
damage, was performed. In tissue from rats treated with PA
(Figure 7c), there was a marked increase in 8-OHdG
immunostaining compared to that in rats pretreated with
DMTU (Figure 7d). Substantiating the previous findings, in
addition to inducing DNA damage in vitro, PA also induced
oxidant-mediated DNA damage in vivo.
Cell cycle checkpoint activation in PAN, oxidant-dependent
To determine if specific cell cycle checkpoint proteins were
activated following PA-mediated oxidative DNA damage,
immunostaining for checkpoint proteins in tissues harvested
from experimental animals was performed. By immunohisto-
chemistry, the number of p21WAF1/CIP1-positive cells by day 7
was increased in the PA group compared to control and
PAþDMTU groups (p21WAF1/CIP1-positive cells per glomer-
ulus: control 0.934, PA 4.061, PAþDMTU 2.026) (control
versus PA, PA versus PAþDMTU: Po0.05) (Figure 8).
Similarly, the number of p53-positive cells by day 7 was
increased in the PA group compared to control and
PAþDMTU groups (p53-positive cells per glomerulus:
control 0.332, PA 5.673, PAþDMTU 2.373) (control versus
PA, PA versus PAþDMTU: Po0.05) (Figure 9). Correlating
with the in vitro data, cell cycle checkpoint proteins p21WAF1/
CIP1 and p53 were activated following exposure to PA. With
DMTU pretreatment, the activation of these specific
checkpoint proteins was reduced.
Apoptosis detection, in vitro and in vivo
Studies have shown that PA may induce podocyte apoptosis
in a dose- and time-dependent manner.20,21 Cleavage of
genomic DNA during apoptosis by specific endonucleases
may yield double- and single-stranded breaks.22 To confirm
that PA-induced apoptosis was not the etiology of the DNA
damage detected under our experimental conditions, de-
signed specifically to avoid apoptosis initiation by utilizing
low doses and short time courses of PA, the terminal
deoxynucleotidyl transferase-mediated dUTP nick end-label-
ing (TUNEL) assay was performed. Figure 10 shows the in
vitro results. Following UV-C irradiation, the positive control
for apoptosis induction, there were 200.75 TUNEL-positive
cells per 1000. However, there was no statistically significant
difference in the number of TUNEL-positive cells among the
control (9.5/1000), PA (18.5/1000), and PAþDMTU (12.5/
1000) groups at 6 h, the time point at which our studies
showed the greatest degree of DNA damage. Figure 11 shows
the in vivo results. TUNEL staining in tissue sections showed
no statistically significant difference in the number of
TUNEL-positive cells among the control (0.6/200 glomeruli),
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Figure 7 | DNA damage induced in PAN, attenuated by pretreatment with DMTU. (a) AP site assay. The number of abasic sites, as
determined by the AP site assay performed on DNA harvested from isolated glomeruli, was significantly increased in rats treated with
PA compared with rats receiving PAþDMTU, at day 1.5. *Po0.05. The difference in abasic sites was not significant at later time points.
(b–d) 8-OHdG immunostaining (original magnification  40): (b) Representative immunostaining for 8-OHdG in control tissues.
(c and d) Representative immunostaining for 8-OHdG in tissues from (c) rats treated with PA alone and (d) rats treated with
PAþDMTU, respectively (arrows indicate positive cells). In tissue from rats treated with PA alone, there was a marked increase in 8-OHdG
immunostaining compared to levels in tissues from rats exposed to PAþDMTU or control conditions.
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PA (1.8/200 glomeruli), and PAþDMTU (1.83/200 glomer-
uli) groups. These data support that apoptosis did not
account for the DNA damage observed under our experi-
mental design.
DISCUSSION
The highly specialized and terminally differentiated podocyte
typically does not proliferate in response to injury. The
detrimental decline in podocyte number post-injury leads to
glomerulosclerosis.2–6 Our group has focused on the
mechanisms underlying the relative inability of podocytes
to proliferate in response to most types of injury. Previously,
we have shown that abnormalities in DNA synthesis, in part,
underlie decreased podocyte number.23 This is largely owing
to specific cyclin-dependent kinase inhibitors.24 A major
finding in this study was that PA induced podocyte DNA
damage, both in vitro and in vivo, accompanied by an
increase in cell cycle checkpoint proteins p53 and p21WAF1/
Cip1. We also showed that increased ROS mediated this effect.
In PAN, the glomerular injury acutely is mediated via
overproduction of ROS,8–13 which then may interact with
biomolecules including DNA, leading to potentially deleter-
ious cellular consequences. Indirect support for the im-
portance of ROS in the pathogenesis of PAN comes from
interventional studies utilizing therapy with antioxidants,
including allopurinol,8 vitamin E,25,26 selenium,26 DMTU,9,13
and grape seed extract.27 These studies have shown beneficial
effects of antioxidants, with reduction in proteinuria and
improvement in glomerular morphologic changes including
foot process effacement. ROS are also important mediators in
the pathogenesis of glomerular injury in other experimental
animal models including passive Heymann nephritis,28 anti-
Thy1 mesangial proliferative glomerulonephritis,29 and
Mpv17 gene-inactivated steroid-resistant focal segmental
glomerulosclerosis.30
A major source of ROS in PA-induced injury is the
podocyte itself, with generation of H2O2, OH
*
, superoxide
anion radical, and lipid peroxidation products.20,31 Increased
ROS are associated with amplification in the activities of
antioxidant enzymes including catalase, superoxide dismu-
tase, and glutathione peroxidase.32 PA may also induce
podocyte apoptosis in a dose- and time-dependent manner,
with apoptosis partially inhibited by ROS scavengers.
Podocyte necrosis has been observed when high concentra-
tions of PA are used.20,21 Furthermore, in vivo studies have
demonstrated increased apoptosis in the glomeruli of
nephrotic animals, accompanied by increased expression of
apoptosis-associated proteins.33
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Figure 8 | Activation of cell cycle checkpoint protein p21WAF1/CIP1 in PAN. By immunohistochemistry (original magnification  40), the
number of p21WAF1/CIP1-positive cells was increased significantly in tissues from rats treated with PA compared with time-matched animals
receiving PAþDMTU (arrows indicate positive cells). (a) Representative immunostaining for p21WAF1/CIP1 in control tissues. (b and d)
Representative immunostaining for p21WAF1/CIP1 in tissues treated with PA only. (c and e) Representative immunostaining for p21WAF1/CIP1
in tissues treated with PAþDMTU. (f) Quantification of p21WAF1/CIP1-positive cells per glomerulus shown in graphic form (150 glomeruli
counted per section  6 animals in each group).
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Prior studies have established that PA induces ultrastruc-
tural changes in podocytes including desquamation from the
glomerular basement membrane,34–36 cytoskeletal disaggre-
gation,36 damage to glomerular basement membrane charge
and size barriers,37,38 and alteration of adhesion molecule
a3b1 integrin distribution and cellular content,
39,40 all
thought to be mediated, at least in part, by overproduction
of ROS. The present study introduced a previously
undescribed mechanism of PA-induced podocyte injury
and dysfunction, namely DNA damage. In cultured podo-
cytes, PA mediated DNA damage, measured by the DNA
precipitation, AP site, and Comet assays. The attenuation of
DNA damage by DMTU provided evidence that the DNA
damage was mediated via ROS. PA-induced DNA damage
was greatest at time point 6 h. Upregulation of DNA repair
enzymes, with subsequent repair of damaged DNA, may
account for the lower levels of DNA damage at later time
points.
Cell cycle checkpoints are signaling pathways that make
up the eukaryotic cell’s response to damaged DNA and
function to coordinate cell cycle progression with DNA
repair, chromatin remodeling, and transcriptional programs.
DNA damage-induced cell cycle arrest provides time for DNA
repair or other cell fate decisions, including apoptosis or
permanent exit from the cell cycle by cellular senescence.41 In
this study, PA-induced DNA damage led to activation of
specific checkpoint proteins, notably p53 and p21WAF1/CIP1,
in cultured podocytes and in experimental PAN.
A possible explanation for why CHK-1 and CHK-2
expression did not substantially differ between podocytes
treated with PA versus PAþDMTU is that diversity exists in
the available array of checkpoint pathways between cells
depending on their distinct cell cycle phase. Based on the
expression, subcellular localization, and stability of specific
proteins, the availability of many checkpoint components
may be limited or lacking at some cell cycle stages.41
Although CHK-1 and CHK-2 potentially could be upstream
mediators of p53, p53 may also be activated by other
checkpoint-transducing kinases including mutated in ataxia
telangiectasia and mutated in ataxia telangiectasia and Rad3-
related.
AP-endonuclease and DNA polymerase-b, two DNA
repair enzymes important in the process of base excision
repair, were increased in cultured podocytes following PA
exposure. Activation of repair enzymes suggested that DNA
damage was present and that the appropriate responses to
injury were triggered in podocytes. With pre-exposure to
DMTU, this activation was lessened significantly, providing
further support that DNA damage was mediated by ROS.
DNA damage was significantly increased in glomeruli
isolated from PA-treated animals versus the glomeruli of
animals receiving PAþDMTU. The difference in the number
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Figure 9 | Activation of cell cycle checkpoint protein p53 in PAN. By immunohistochemistry (original magnification  40), the number of
p53-positive cells was increased significantly in tissues from rats treated with PA compared with time-matched animals receiving PAþDMTU
(arrows indicate positive cells). (a) Representative immunostaining for p53 in control tissues. (b and d) Representative immunostaining for
p53 in tissues treated with PA only. (c and e) Representative immunostaining for p53 in tissues treated with PA and DMTU. (f) Quantification
of p53-positive cells per glomerulus shown in graphic form (150 glomeruli counted per section  6 animals in each group).
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of abasic sites between the two groups was most notable at
the earliest time point. By day 7, the level of abasic sites had
declined in both groups. This decline may be attributable to
repair of damaged DNA. TUNEL staining confirmed that PA-
induced apoptosis was not a significant mechanism of injury
under our experimental conditions.
We conclude that podocyte injury in the PAN model is, in
part, mediated by the oxidizing properties of PA. In addition
to the DNA damage found in the passive Heymann nephritis
model of immune-mediated podocyte injury,23 we demon-
strated that DNA damage may be a more generalized
response to injury. The overproduction of ROS induced
podocyte DNA damage, leading to activation of checkpoint
pathways to arrest or delay cell cycle progression. The
resulting cell cycle arrest may be a mechanism underlying the
podocyte’s relative inability to proliferate following PA-
induced injury. In combination with PA-induced podocyte
loss from other mechanisms, including apoptosis20,31,33 and
detachment,35 the lack of podocyte proliferation may
contribute to reduced podocyte number and areas of
denuded basement membrane, ultimately leading to the
development of glomerulosclerosis and the progressive
deterioration in kidney function.
Whether antioxidant strategies will be useful therapeutic
interventions in the setting of injury induced by oxidizing
podocyte toxins is unclear. There are many potential
antioxidant therapies, ranging from endogenous enzymes/
compounds (glutathione peroxidase-like molecules, epoetin)
and trace elements (selenium) to drugs (angiotensin-
converting enzyme inhibitors, b-blockers, statins, N-acetyl-
cysteine, and metal ion chelators) and dietary antioxidants
(phytoestrogens).42 Further studies are needed to clarify the
therapeutic potential of antioxidants in non-immune-
mediated podocyte injury.
MATERIALS AND METHODS
Primary antibodies
Antibodies for Western blotting and immunostaining included
mouse monoclonal antibodies: anti-p21WAF1/CIP1 (BD Biosciences,
San Diego, CA, USA), anti-p53 (BD Biosciences; Oncogene Research
Products, San Diego, CA, USA), anti-DNA polymerase-b (Alpha
Diagnostic International, San Antonio, TX, USA), anti-AP-endo-
nuclease (Trevigen, Gaithersburg, MD, USA), anti-8-OHdG (Trevi-
gen), anti-b-tubulin (Sigma-Aldrich, St Louis, MO, USA), anti-actin
(Chemicon International, Temecula, CA, USA), and anti-glycer-
aldehyde-3-phosphate dehydrogenase (Abcam, Cambridge, MA,
USA).
Mouse podocytes in culture
A conditionally immortalized mouse podocyte cell line isolated
from H-2Kb-tsA58 transgenic mice kidneys (Jackson Laboratory,
Bar Harbor, ME, USA) was used in vitro.43–45 In this cell line,
g-interferon-inducible H-2Kb promoter controls a temperature-
sensitive SV40 large T-cell antigen. To induce proliferation, cells
were grown on Primaria plates (VWR International, West Chester,
PA, USA) coated with collagen I (BD Biosciences) at 331C in
Rosewell Park Memorial Institute 1640 media (Invitrogen, Grand
Island, NY, USA) supplemented with 10% fetal calf serum (Hyclone,
Logan, UT, USA), with added recombinant mouse g-interferon
50 U/ml (Roche, Indianapolis, IN, USA).46 To induce the quiescent,
differentiated phenotype, cells were grown at 371C without
g-interferon (growth-restrictive condition). Experiments were
performed at least three times, on growth-restricted days 12–14,
utilizing more than one cell clone to verify reproducibility of results.
The cell lines were derived in our lab, identified and characterized
by immunostaining and reverse transcription-polymerase chain
reaction, as described previously.47
DNA damage detection in vitro following exposure to PA
Following preliminary dose-defining studies, the DNA precipitation
assay48 was used to detect PA-induced DNA damage. After
incubation with 0.5 mCi/ml 3H-thymidine to allow for DNA
incorporation, podocytes were exposed to PA 30 mg/ml for 2 h.
Cells were washed with Hank’s Balanced Salt Solution (Irvine
Scientific, Santa Ana, CA, USA) and incubated in medium until a
series of time points. At time of harvest, podocytes were lysed,
incubated with 12 M KCl at 651C for 10 min, iced for 5 min, and
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Figure 10 | Apoptosis detection following PA exposure, in vitro.
TUNEL staining of cultured podocytes. Representative images of
podocytes exposed to (a) negative control conditions (b) positive
control, UV-C irradiation (c) PA, and (d) PAþDMTU. Arrows indicate
TUNEL-positive cells. (original magnification 20). (e) Quantification
of TUNEL-positive cells per 1000 cells counted. There is no significant
difference in the number of TUNEL-positive cells between negative
control, PA, and PAþDMTU treatment groups (time point 6 h
shown).
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centrifuged (3200 g) to separate precipitated chromatin DNA from
damaged DNA (supernatant). Supernatants and DNA pellets were
dissolved separately in scintillation fluid and counted in a Beckman
3500 scintillation counter. The percentage of ssDNA was calculated.
ROS commonly induce depurination and depyrimidination.7
Therefore, the AP site assay was the second detection method of PA-
induced DNA damage, using the DNA damage quantification kit
(Dojindo Molecular Technologies, Gaithersburg, MD, USA). Briefly,
DNA was isolated from podocytes using the DNeasy isolation kit
(Qiagen, Valencia, CA, USA). AP sites were detected using an
aldehyde-reactive probe reagent. AP sites were tagged with biotin,
and the DNA was bound to a microtiter plate along with aldehyde-
reactive probe-tagged DNA standards. The sites were visualized
using peroxidase streptavidin. The number of AP sites in the sample
DNA was determined by comparing absorbance at 650 nm to the
standard curve.
To confirm PA-induced DNA damage, the single-cell gel
electrophoresis assay (Comet assay) (Trevigen), was utilized.49–51
Briefly, podocytes were gently harvested and embedded in an
agarose layer on a microscope slide. Cells were lysed to remove
cellular proteins and DNA was uncoiled under alkaline conditions.
After unwinding, DNA was electrophoresed for 20 min under
alkaline conditions and stained with fluorescent dye. In contrast
to undamaged and supercoiled DNA that remains within the nuclear
cell membrane, the podocytes with damaged DNA, which migrated
away from the nucleus, demonstrated the characteristic long ‘comet
tail’. The extent of DNA liberated from the head of the ‘comet’ was
directly proportional to DNA damage.
DNA damage detection in vitro following exposure to
PA7DMTU
Studies have highlighted the importance of hydroxyl radical (OH
*
)
in ROS-mediated injury during the induction phase of PAN.10
Highly reactive and toxic, OH
*
can generate modifications in DNA
including sugar/base alterations, strand breaks, and DNA–protein
cross-links.15,16,43 To determine the role of oxidants in PA-induced
DNA damage, podocytes were pretreated with the OH
*
scavenger
DMTU (Sigma-Aldrich).
One hour before PA exposure, podocytes were incubated in
medium with DMTU 10 mM. One-hour incubation with 2.5 mM
H2O2 served as the positive control for oxidant-induced DNA
damage. Although H2O2 itself is considered relatively non-reactive
toward DNA, much of the H2O2-mediated DNA damage is
secondary to OH
*
generation via the Fenton reaction.7
Western blot analysis
Because activated checkpoints induce cell cycle arrest following
exposure to DNA-damaging agents,7 Western blotting was per-
formed to measure the expression of specific cell cycle checkpoint
proteins in podocytes exposed to PA7DMTU.52 Cells were
harvested by trypsin digestion and pelleted by centrifugation
(1200 r.p.m. for 5 min). Protein was extracted using TG buffer,46
in the presence of a protease inhibitor cocktail (Roche) and
phosphatase inhibitors sodium orthovanadate and sodium
fluoride (Sigma-Aldrich). Following a freeze–thaw cycle, lysates
were cleared by centrifugation (16 000 r.p.m. for 10 min), and
protein concentrations were determined by the bicinchoninic acid
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Figure 11 | Apoptosis detection following PA exposure, in vivo. TUNEL staining of tissue sections. Representative images of tissue sections
from rats in (a) control group versus (b and d) groups treated with PA alone or (c and e) PAþDMTU. (d and e) TUNEL-positive cells in the
tubulointerstitium adjacent to glomeruli without positive cells. (f) Quantification of TUNEL-positive cells per 200 glomeruli counted. There is no
significant difference in the number of TUNEL-positive cells between control, PA, and PAþDMTU treatment groups.
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protein assay (Pierce, Rockford, IL, USA). Protein extracts of
5–15 mg were separated under reduced conditions on 12–15%
sodium dodecyl sulfate-polyacrylamide gels and transferred to
polyvinyl difluoride membranes (PerkinElmer, Boston, MA,
USA).24,53,54 Membranes were incubated with antibodies to
p21WAF1/CIP1, p53, growth arrest, DNA damage-inducible-45a, AP-
endonuclease, DNA polymerase-b, CHK-1, and CHK-2. To ensure
equal protein loading, antibodies to housekeeping proteins tubulin,
actin, and glyceraldehyde-3-phosphate dehydrogenase were used.
Bands were detected with chromagen 5-bromo-4-chloro-3-inodyl
phosphate/nitro blue tetrazolium (Sigma-Aldrich). Densitometry
was performed with the NIH image analysis program ImageJ. Three
separate experiments were performed for each Western blot analysis
and the densitometry results were averaged, with normalization for
differences in protein loading.
PAN model
To test the hypothesis that PA induced podocyte DNA damage in
vivo, the PAN model55 was induced in male Sprague–Dawley rats
(Charles River Laboratories, Wilmington, MA, USA). After
preliminary studies to define the optimal dose to achieve mild-to-
moderate disease, identifying a dose that would cause DNA damage
without significant accompanying apoptosis or necrosis, rats aged 60
days, weighing 200–300 g, were divided into treatment groups
(n¼ 6/group/time point): PA, PAþDMTU, and control, killed at
days 1.5, 3, and 7.8,9,56,57 The PA groups received a single injection of
PA dissolved in 0.9% NaCl, at 6 mg/100 g body weight via tail vein.
The PAþDMTU groups received DMTU dissolved in 0.9% NaCl,
500 mg/kg intraperitoneally one hour before PA injection, then
125 mg/kg intraperitoneally twice a day until killing. The control
animals were injected with equal volume of 0.9% NaCl substituted
for both PA and DMTU. Each animal was anesthetized with 100%
ethyl ether (VWR) in an inhalation chamber before tail vein
injections. Animals were anesthetized in an isoflurane (Halocarbon
Labs, North Augusta, SC, USA) and oxygen vaporizer chamber
before intraperitoneal injections. Before killing, urine collections
were obtained in metabolic cages to determine 24-h protein
and creatinine excretion. Urine protein was measured by the
sulfosalicylic acid method (standards from Dade Diagnostics,
Brisbane, Australia).58 Urine creatinine levels were determined
via a colorimetric microplate assay (Oxford Biomedical, Oxford,
MI, USA). Death was induced by exsanguination following
anesthetization with 100% ethyl ether. Blood samples, obtained
at time of killing via vena caval puncture, were centrifuged
(12 000 g for 5 min) and plasma was collected for measurement of
blood urea nitrogen (Sigma-Aldrich). Tissues were obtained for
renal biopsies and glomerular isolation. All animal procedures
were conducted in accord with the Institutional Animal Care and
Use Committee.
Isolation of glomeruli
Preparation of isolated glomeruli was performed at 41C, with kidney
tissue from one rat used per preparation.52 After discarding medulla
and papilla, finely minced cortices were passed through three
differential sieves (200, 140, and 80 mm) using 2000 ml of normal
saline. Glomeruli were washed and resuspended in 50 ml of saline.
Quantitation of glomeruli was performed in aliquots of glomerular
suspension by phase microscopy, with purity 495% for all
preparations. Following centrifugation (1000 r.p.m. at 41C for
10 min), supernatant was decanted, and DNA isolation and
purification was performed from the pelleted glomeruli.
Measuring DNA damage in vivo
DNA was isolated and purified from glomerular isolates via the
DNeasy tissue kit. DNA damage was detected by counting abasic
sites using the DNA damage quantification kit.
Immunohistochemistry
Indirect immunoperoxidase immunostaining was performed on
formalin-fixed paraffin-embedded kidney specimens.53 Briefly, 4-
mm tissue sections were deparaffinized in Histo-Clear (National
Diagnostics, Atlanta, GA, USA) and rehydrated in graded ethanol.
Endogenous peroxidases were blocked with 3% H2O2, followed by
overnight incubation with primary antibody diluted in 1% bovine
serum albumin in phosphate-buffered saline (PBS). After washing in
PBS, sections were incubated with biotinylated secondary antibody,
diluted in 1% bovine serum albumin in PBS, for 1 h at room
temperature. ABC (Avidin and Biotinylated horseradish peroxidase
macromolecular Complex)-Elite reagent (Vector Laboratories,
Burlingame, CA, USA) was used for signal amplification and 3,30-
diaminobenzidine (Sigma-Aldrich) catalyzed by NiCl2 was used
as chromagen. Slides were counterstained with methyl green,
dehydrated, and coverslipped.
Immunostaining for 8-OHdG, was performed on methacarn-
fixed tissue.59 Briefly, following deparaffinization and rehydration,
slides were pretreated with proteinase K (Roche) and RNase
(Qiagen). DNA was denatured with 4 N HCl, followed by Tris-
buffered saline neutralization. 10% fetal calf serum in 10 mM Tris-
HCl was used to block unspecific sites. Sections were incubated
overnight at 41C with primary antibody diluted in 10 mM Tris-HCl,
10% fetal calf serum . After washing with PBS, sections were incu-
bated with the secondary antibody at 371C for 30 min. ABC-Elite
reagent was used for signal amplification. 3,30-diaminobenzidine
with 30% H2O2 was used as chromagen. Slides were counterstained
with hematoxylin, dehydrated, and coverslipped.
Apoptosis detection
TUNEL staining was utilized to exclude the possibility of significant
apoptosis under our experimental conditions. The protocol was a
modification of methods described previously.60 Briefly, cultured
podocytes were fixed with 10% buffered formalin overnight at 41C.
Following rehydration with PBS, endogenous peroxidases were
inactivated with 3% H2O2. Cells were treated with citric acid to
enhance antigen retrieval. Nuclei were permeabilized by incubation
with proteinase K for 20 min at room temperature. Following
incubation in One-Phor-All buffer (GE Healthcare, Piscataway, NJ,
USA), fragmented DNA was labeled by exposure of cells to diluted
terminal deoxynucleotidyl transferase (GE Healthcare) and biotin-
14-dATP (Invitrogen) for 60 min. The reaction was terminated with
PBS. ABC-Elite reagent was used for signal amplification. 3,30-
diaminobenzidine with NiCl2 was used as chromagen. Cells were
counterstained with Camco Quik stain (Cambridge Diagnostic, Fort
Lauderdale, FL, USA).
Similarly, in vivo, TUNEL staining was performed on 4-mm
formalin-fixed paraffin-embedded tissue sections. Following depar-
affinization and rehydration, the above protocol was followed. Slides
were counterstained with methyl green, dehydrated, and cover-
slipped.
Statistical analysis
For comparison of mean values between two groups, the unpaired
t test was used. All values are means7s.d. except where otherwise
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indicated. The experimental findings were considered statistically
significant if Po0.05. All photomicrographs were made at similar
intensity and background. During data analysis, the observer was
blinded to the treatment categories.
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